About this trial
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.
Eligibility criteria
Qualifiers
HCW, OA and ST who received COVID-19 vaccine.
Participating subjects should be at least 18-year-old and able to give their informed consent independently.
Disqualifiers
Non HCW, OA and ST who received the COVID-19.
Trial design
Treatments tested in this trial
- BNT162b2
- mRNA-1273
- AZD1222
- CoronaVac
- Sinopharm
- Gam-COVID-Vac
- JNJ-78436735
- CVnCoV
- NVX-CoV2373
- BBV152
Treatment groups
11
Treatment groupsSee each treatment group below.